DANIEL DONOVAN
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
MICHAEL T CULLEN, MICHAEL T. CULLEN, ARTHUR J. FRATAMICO, SUZANNE GAGNON, DALVIR S GILL, DALVIR S. GILL, SUSAN HORVATH, SUSAN M. HORVATH, JEFFREY E. JACOB, DAVID B KAYSEN, DAVID B. KAYSEN, SCOTT KELLEN, JEFFREY S MATHIESEN, JEFFREY S. MATHIESEN, J. ROBERT PAULSON, J. ROBERT PAULSON, JR., PAUL W SCHAFFER, PAUL W. SCHAFFER, D. ROBERT SCHEMEL, ROBERT SCHEMEL, ROBERT D. SCHEMEL, JENNIFER K. SIMPSON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2024-11-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-12-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-11-02
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-06-15
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-01-20
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-09-06
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-04-10
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2016-01-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2015-12-31

